Trial intelligence / Profile preview

Melatonin for sleep quality in adult intensive care unit patients

IRCT20191105045342N1Phase 3Completed

Sponsor
Gonabad University of Medical Sciences
Start
Dec 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of melatonin in sleep disorder (2 arms), sponsored by Gonabad University of Medical Sciences. Primary endpoints: pain score, sleep quality and 1 more. Started Dec 2019; status: completed.

02

Drugs

melatonin
03

Conditions

sleep disorder

Beyond the preview

Go deeper on IRCT20191105045342N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20191105045342N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call